About KyDo Therapeutics
KyDo Therapeutics GmbH (KyDo) is a preclinical-stage biotechnology company committed to developing novel covalent- allosteric small molecule inhibitors with the potential to become first-in-class oncology drugs. KyDo was jointly founded by Lead Discovery Center GmbH (LDC) together with scientists from the Rauh Lab at TU Dortmund University.
Facts about KyDo Therapeutics
Facts about KyDo Therapeutics
- Focus : Manufacturer
- Industry : Biotechnology, Pharma
Advertisement
